Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,238,357
+$42,068 QoQ
Shares Held
4,876
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#2,797
of 4,676 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VICUS CAPITAL holds $5,105,271 across 9 Drug Manufacturers - General names. JNJ ranks #1 (24.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
4,876 | $1,238,357 | |
| 2 | ABBV |
AbbVie Inc.
|
3,138 | $789,646 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,836 | $749,926 | |
| 4 | LLY |
ELI LILLY & Co
|
584 | $700,467 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,416 | $431,577 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,303 | $363,178 | |
| 7 | NVS |
Novartis AG
|
2,251 | $352,776 | |
| 8 | AMGN |
Amgen Inc
|
716 | $259,277 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,238,357 | 4,876 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,196,289 | 4,894 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,028,541 | 4,970 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $1,150,531 | 6,205 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $775,359 | 5,076 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $843,130 | 5,084 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $790,203 | 5,464 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $868,641 | 5,360 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,004,119 | 6,870 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $1,119,352 | 7,076 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $974,922 | 6,220 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,226,219 | 7,873 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $1,018,279 | 6,152 | Shares | Sole | 2023-08-17 | |
| 2023-03-31 | $1,014,630 | 6,546 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,195,037 | 6,765 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $2,114,695 | 12,945 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,344,283 | 7,573 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,182,124 | 6,670 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,128,719 | 6,598 | Shares | Sole | 2022-02-10 | |
| 2021-03-31 | $1,300,172 | 7,911 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,169,490 | 7,431 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $1,124,788 | 7,555 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,108,305 | 7,881 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,068,971 | 8,152 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||